Document is current
Any future updates will be listed below
-
Authors
Migaud, Marie E. https://orcid.org/0000-0002-9626-2405
Ziegler, Mathias https://orcid.org/0000-0001-6961-2396
Baur, Joseph A.
- License Information
-
More Information
Article History
Accepted: 5 June 2024
First Online: 18 July 2024
Competing interests
: M.E.M. is supported, in part, by Elysium Health and holds a patent on manufacturing the oxidized and reduced forms of nicotinamide adenine dinucleotide (NAD<sup>+ </sup>and NADH) precursors, their derivatives and applications thereof. M.Z. is scientific adviser for Blue Helix Health and declares no other competing interests. J.A.B. has received research funding and materials from Pfizer, Calico, Elysium Health and Metro International Biotech and consulting fees from Pfizer, Elysium Health, Cytokinetics and Altimmune, and holds a patent for using NAD<sup>+</sup> precursors in liver injury.
